Company / Current Liabilities
Vericel Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$49.1M
FY2025
5-year range
$26.1M / $50.3M
FY2021-FY2025
Trend
-2.3%
vs FY2024
Sector context
#141 of 213
Health Care
What the data says
At $49M, Vericel's current liabilities ranks #73 of 213 in the Health Care sector. Increased from $46M to $49M over the past 2 years.
Based on SEC 10-K filings.
$49M in FY2025 with a 5-year CAGR of +16.9%.
Increased from $46M to $49M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +9.5%
- 5-Year CAGR
- +16.9%
- 10-Year CAGR
- -
Sector benchmark
#73 of 213 in Health CareTop 34% of 213This company $49.1M Sector average $1.6B
▼
-96.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +16.9%, indicating consistent growth.
- In FY2025, current liabilities decreased 2.3% year-over-year.
- Ranks #141 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $49.1M | -2.3% |
| FY2024 | $50.3M | +9.9% |
| FY2023 | $45.7M | +22.1% |
| FY2022 | $37.5M | +43.8% |
| FY2021 | $26.1M | +15.9% |
| FY2020 | $22.5M | +13.6% |
| FY2019 | $19.8M | +33.8% |
| FY2018 | $14.8M | +13.0% |
| FY2017 | $13.1M | +1.8% |
| FY2016 | $12.9M | +6.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026